New Drug Applications Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease 1 year ago
Pharma Industry News Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report 1 year ago
Pharma Industry News Siemens Acquires Dotmatics, Extending AI Software Portfolio into Life Sciences 1 year ago